Genetic Testing in Westbury, NY: Using DNA Data to End the Guess-Adjust-Wait Cycle in Psychiatric Care

Ask any psychiatrist how they decide which antidepressant to try first, and the honest answer involves pattern recognition more than certainty. Symptoms get weighed. Side effect profiles get compared. Family response history gets factored in when available. But once the prescription is written, everyone waits. Three or four weeks pass before there’s enough data to know whether the choice landed. If it didn’t, the cycle restarts. Patients who need help now often spend the better part of a year finding out which options were never going to work.

The starting point can be smarter. Pharmacogenomic testing shows how your specific DNA responds to psychiatric medications, meaning the first prescription can be shaped by biology instead of statistical odds. Our team at Anxiety & Depression Psychiatry offers genetic testing in Westbury, often paired with our ketamine therapy service in Westbury, with additional research context available through the U.S. National Library of Medicine MedlinePlus Genetics.

The sample collection itself is straightforward: a soft swab against the inside of your cheek, done either in our office or through a mail-in kit sent to your home. Once processed, results come back to us within roughly a week and cover interactions with about 130 psychiatric medications. What we look at falls into three clinical categories.

Some practices treat genetic testing as a last resort, reaching for it only after multiple medications have already failed. That approach costs patients time they can’t get back.

The math on that decision is worth being blunt about. Depression is estimated to be roughly 40 percent genetic and 60 percent environmental. Each new medication trial takes at least three to four weeks to evaluate. Failed trials produce side effects, disrupt daily functioning, and, more quietly, wear down the belief that anything will eventually help. Every unsuccessful prescription is more than just a scheduling problem.

Starting with genetic data changes the shape of that early period. It doesn’t guarantee that the first medication will be the one, but it removes the medications your biology was never going to accommodate — which for a lot of patients is the difference between finding relief this quarter and finding it next year.

Pharmacogenomic testing is a real clinical tool, but it isn’t a diagnostic oracle. It can’t tell us that a specific medication will work. What it can do is confirm that your genetics don’t create an obvious obstacle. It doesn’t replace clinical judgment, and it doesn’t stand in for a full psychiatric evaluation. The test is a layer, not the whole picture.

Skeptics still argue that the science hasn’t matured enough for routine use. That argument is losing ground. Medicare, Medicaid, and United Healthcare all reimburse pharmacogenomic testing, which is a strong regulatory signal that the evidence base has held up under scrutiny. A genetic testing clinic in Westbury, NY working within those coverage frameworks is operating in a fundamentally different landscape than the field did five years ago.

Patients who react badly to several psychiatric medications used to be described as sensitive, difficult, or overly reactive. The language pathologized what turns out to be, in many cases, straightforward biology. If you’ve been unable to tolerate multiple medications at standard doses, there’s a good chance you carry a slow-metabolizer genotype that causes drugs to accumulate in your system.

Naming that dynamic isn’t cosmetic. Once we know how your body handles a given drug class, we can select medications and doses your physiology can actually tolerate, which usually changes the entire clinical trajectory.

Genetic testing in Westbury, NY can shift what your first treatment decision looks like. Call us at (646) 830-0131 to schedule a consultation and learn whether pharmacogenomic testing is right for you.

I feel that, although it is new, psychopharmacogenomic testing is a game changer for psychiatry. — Dr. Tomer Levin